HDAC3 Inhibition Ameliorates Ischemia/reperfusion-induced Brain Injury by Regulating the Microglial CGAS-STING Pathway
Overview
Authors
Affiliations
It is known that neuroinflammation plays a critical and detrimental role in the development of cerebral ischemia/reperfusion (I/R), but the regulation of the cyclic GMP-AMP synthase (cGAS)-mediated innate immune response in I/R-induced neuroinflammation is largely unexplored. This study aimed to investigate the function and regulatory mechanism of cGAS in I/R-induced neuroinflammation and brain injury, and to identify possible strategies for the treatment of ischemic stroke. To demonstrate that microglial histone deacetylase 3 (HDAC3) regulates the microglial cGAS-stimulator of interferon genes (cGAS-STING) pathway and is involved in I/R-induced neuroinflammation and brain injury, a series of cell biological, molecular, and biochemical approaches were utilized. These approaches include transient middle cerebral artery occlusion (tMCAO), real-time polymerase chain reaction (PCR), RNA sequencing, western blot, co-immunoprecipitation, chromosome-immunoprecipitation, enzyme-linked immunosorbent assay (ELISA), dual-luciferase reporter assay, immunohistochemistry, and confocal imaging. The microglial cGAS- STING pathway was activated by mitochondrial DNA, which promoted the formation of a pro-inflammatory microenvironment. In addition, we revealed that HDAC3 transcriptionally promoted the expression of cGAS and potentiated the activation of the cGAS-STING pathway by regulating the acetylation and nuclear localization of p65 in microglia. Our results indicated that deletion of cGAS or HDAC3 in microglia attenuated I/R-induced neuroinflammation and brain injury. Collectively, we elucidated that the HDAC3-p65-cGAS-STING pathway is involved in the development of I/R-induced neuroinflammation, identifying a new therapeutic avenue for the treatment of ischemic stroke.
Quan S, Fu X, Cai H, Ren Z, Xu Y, Jia L Mol Neurodegener. 2025; 20(1):25.
PMID: 40038765 PMC: 11877805. DOI: 10.1186/s13024-025-00815-2.
Microglial Mechanisms and Therapeutic Potential in Brain Injury Post-Intracerebral Hemorrhage.
Gong Y, Li H, Cui H, Gong Y J Inflamm Res. 2025; 18:2955-2973.
PMID: 40026311 PMC: 11872102. DOI: 10.2147/JIR.S498809.
Targeting the PRMT1-cGAS-STING signaling pathway to enhance the anti-tumor therapeutic efficacy.
Huang D, Rezaeian A, Wang J, Qi Y, Chen H, Inuzuka H J Cancer Biol. 2025; 5(2):44-60.
PMID: 40018367 PMC: 11867627. DOI: 10.46439/cancerbiology.5.064.
Cui Y, Liu J, Song Y, Chen C, Shen Y, Xie K CNS Neurosci Ther. 2025; 31(2):e70305.
PMID: 40016173 PMC: 11867788. DOI: 10.1111/cns.70305.
HDAC3: A Multifaceted Modulator in Immunotherapy Sensitization.
Han R, Luo Y, Gao J, Zhou H, Wang Y, Chen J Vaccines (Basel). 2025; 13(2).
PMID: 40006729 PMC: 11860249. DOI: 10.3390/vaccines13020182.